Google
×
Proxygen harnesses cutting-edge technology and know-how to exploit this potential, thereby redefining the borders of druggable target space. A wide-spanning ...
People also ask
Proxygen is a biotechnology firm specializing in protein degradation therapy for treatment of cancer and other life threatening dieseses.
Proxygen develops innovative therapies against cancer and other life-threatening diseases by reprogramming the cellular protein quality control system.
Apr 5, 2023 ˇ The company has signed a licensing agreement with Merck & Co. worth more than $2.55 billion in biobucks, according to an announcement Wednesday.
Aug 31, 2020 ˇ Proxygen is a Vienna-based startup that develops therapies against cancer and other life-threatening diseases by reprogramming the cellular ...
Operator of a biotechnology company intended to develop innovative therapies against cancer and other life-threatening diseases. The company uses molecular glue ...
Proxygen GmbH is a startup company with the mission to develop therapies against cancer and other life-threatening diseases by reprogramming ... www.proxygen.com.